XNPT Volume and PPS up substantially over the past few weeks. I'm willing to bet that someone thinks the long-awaited ex-Asian partnerships are coming soon for the gabapentin and/or baclofen analogs. In the current environment, one or more partnerships could mean very significant upside even from here.